Log In
Print this Print this

Invega, paliperidone ER

Also known as: Xeplion, paliperidone prolonged-release (Paliperidone (Oros) ER)

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionMetabolite of Risperdal risperidone, a selective monoaminergic antagonist
Molecular Target Monoamine receptors
Mechanism of ActionMonoaminergic receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationSchizophrenia
Indication DetailsTreat adolescent schizophrenia; Treat schizoaffective disorder; Treat schizophrenia; Treat schizophrenia in adolescent patients ages =>15 years
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today